Wanbangde Pharmaceutical Holding Group Co., Ltd. (SHE:002082)
5.62
-0.19 (-3.27%)
Apr 30, 2025, 3:04 PM CST
SHE:002082 Revenue
In the year 2024, Wanbangde Pharmaceutical Holding Group had annual revenue of 1.44B CNY, down -6.39%. Wanbangde Pharmaceutical Holding Group had revenue of 368.87M in the quarter ending December 31, 2024, a decrease of -29.61%.
Revenue
1.44B
Revenue Growth
-6.39%
P/S Ratio
2.38
Revenue / Employee
899.29K
Employees
1,605
Market Cap
3.44B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 1.44B | -98.57M | -6.39% |
Dec 31, 2023 | 1.54B | -244.49M | -13.69% |
Jan 1, 2023 | 1.79B | -144.17M | -7.47% |
Jan 1, 2022 | 1.93B | -11.77B | -85.91% |
Dec 31, 2020 | 13.70B | -2.99B | -17.91% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 29.19B |
Shenzhen Mindray Bio-Medical Electronics | 37.11B |
WuXi AppTec | 39.59B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.79B |
Aier Eye Hospital Group | 21.81B |
Sichuan Biokin Pharmaceutical | 5.82B |
Shanghai United Imaging Healthcare | 10.30B |
Yunnan Baiyao Group Co.,Ltd | 40.10B |